Literature DB >> 2962941

Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure.

M Pepi1, M Alimento, A Maltagliati, M D Guazzi.   

Abstract

In hypertension, coronary flow is augmented and oxygen balance is adequate despite an increase in coronary resistance. For the maintenance of flow in the presence of and after regression of ventricular hypertrophy, the ratio of pressure and ventricular mass must remain normal. Coronary reserve would be altered if treatment normalized pressure but not ventricular mass or if pressure were lowered too fast. We investigated 42 patients with primary hypertension. In 28 (Group I) left ventricular mass index (by ultrasound) was within the mean value +2 SD (96 + 38 g/m2) of 145 controls and exceeded these values in the remaining 14 patients (Group 2). The diastolic pressure was lowered rapidly to between 85 and 90 mm Hg with two potent vasodilators, nifedipine (sublingually) and nitroprusside, while a 12-lead electrocardiogram was recorded continuously. During both tests, seven patients in Group 2 (responders) showed inversion of normal T waves, in lead I, aVL, and V3-6. These changes waxed and waned in parallel with the pressure fall and recovery and were not attributable to alterations in adrenergic tone, conduction disturbances, variations, or group differences in the QRS axis, QTc interval, heart rate, left ventricular fractional shortening, wall stress, rate of dimension increase in early diastole, or isovolumic relaxation. A ""steal phenomenon'' or passive collapse in compliant coronary lesions during vasodilatation seems unlikely; in fact, patients were free from coronary symptoms, and the electrocardiographic alterations occurred only in seven patients in Group 2, who had a greater left ventricular mass index and required a larger pressure drop to return the diastolic pressure to normal.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962941     DOI: 10.1161/01.hyp.11.1.84

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease.

Authors:  Monisankar Roy; Noman Mahmood; Clive Rosendorff
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 2.  The optimal blood pressure target for patients with coronary artery disease.

Authors:  Paolo Verdecchia; Fabio Angeli; Claudio Cavallini; Giovanni Mazzotta; Marta Garofoli; Paola Martire; Gianpaolo Reboldi
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

Review 3.  Lowering blood pressure. How far, how fast?

Authors:  A Roca-Cusachs
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 4.  Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin.

Authors:  Goran Koracevic; Milovan Stojanovic; Tomislav Kostic; Dragan Lovic; Miloje Tomasevic; Ruzica Jankovic-Tomasevic
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

5.  Blood pressure and myocardial infarction. Low blood pressure can be hazardous.

Authors:  J M Cruickshank
Journal:  BMJ       Date:  1994-05-14

Review 6.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

Review 7.  J curve in antihypertensive therapy--does it exist? A personal point of view.

Authors:  J M Cruickshank
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

8.  Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?

Authors:  P Owens; E O'Brien
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

Review 9.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

Review 10.  The J-curve in hypertension.

Authors:  John Cruickshank
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.